Internal Medicine, Hematology & Oncology · Montgomery, AL
NPI
1902852171
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4145 Carmichael Rd
Montgomery, AL, 36106
Phone (334) 273-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
589 services
Medicare patients, 2024
384
Average age 75
Drug cost, 2024
$5.7M
3,177 prescriptions
Company payments, 2025
$573
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen L Davidson was code 99215 (office e&m - established), 250 times for 187 patients. In total Stephen L Davidson billed 589 services in 6 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 250 | 187 | $94.66 | $24K |
| 99214 Office E&M - Established | Office | 248 | 197 | $62.98 | $16K |
| 99205 Office E&M - New | Office | 73 | 73 | $129.11 | $9,425 |
| 99204 Office E&M - New | Office | 13 | 13 | $68.43 | $890 |
By year: 2022 $70K for 834 services; 2023 $58K for 693 services; 2024 $50K for 589 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen L Davidson prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 377 prescriptions and refills. In total Stephen L Davidson wrote 3,177 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 377 | 377 | 90 | $10K |
| Exemestane Generic | 209 | 440 | 66 | $43K |
| Gabapentin Generic | 208 | 212 | 58 | $2,121 |
| Prochlorperazine Maleate Generic | 164 | 164 | 108 | $1,924 |
| Fentanyl Generic | 159 | 159 | 32 | $15K |
| Ondansetron Odt Ondansetron | 153 | 153 | 123 | $1,948 |
| Letrozole Generic | 130 | 261 | 40 | $2,571 |
| Dexamethasone Generic | 123 | 132 | 66 | $1,163 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 117 | 117 | 27 | $2,955 |
| Revlimid Lenalidomide | 111 | 111 | 18 | $2.1M |
| Ciprofloxacin Hcl Generic | 93 | 93 | 80 | $124 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 88 | 88 | 75 | $136 |
| Compro Prochlorperazine | 72 | 72 | 64 | $2,925 |
| Morphine Sulfate Er Morphine Sulfate | 62 | 62 | 13 | $1,909 |
| Anastrozole Generic | 52 | 92 | 14 | $854 |
Brand drugs: 493 claims; generic drugs: 2,684 claims; opioid claims: 779.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen L Davidson $573 ($573 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $104.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $104 |
| Celgene Corporation BMY | 3 | $64.74 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $58.71 |
| Astellas Pharma US Inc 4503.T | 3 | $54.97 |
| Array Biopharma Inc PFE | 3 | $52.32 |
| BeOne Medicines USA, Inc. ONC | 2 | $37.79 |
| Gilead Sciences, Inc. GILD | 2 | $37.04 |
| SpringWorks Therapeutics, Inc. | 2 | $35.06 |
| GlaxoSmithKline, LLC. GSK | 2 | $31.68 |
| BeiGene USA, Inc. ONC | 1 | $29.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.